Literature DB >> 31209512

Treatment and Outcome of 341 Papillary Breast Lesions.

Peixian Chen1, Dan Zhou2, Chuan Wang3, Guolin Ye4, Ruilin Pan2, Lewei Zhu2.   

Abstract

BACKGROUND: Papillary breast lesions constitute a pathological heterogeneous group and display diverse clinical and imaging features. This study was conducted to analyze the upgrade rate of intraductal papilloma diagnosed on core needle biopsy and to assess the possible risk factors associated with upgrade to higher-risk lesions. We also examined the long-term outcomes in patients who received resection of the papillary lesions.
MATERIALS AND METHODS: The clinical and pathology records of 324 female patients who were diagnosed with papillary lesions based on core needle biopsy (CNB) from February 2010 to October 2016 at our institution were retrospectively analyzed. Patients were grouped by initial diagnosis into two groups (papilloma with or without atypia) and followed-up for long-term outcomes. For the upgrade to higher-risk lesions after excision, upgraded lesions were compared with benign papillomas for the collected variables.
RESULTS: A total of 341 lesions were included for final analysis, and all were available for follow-up. Papillomas with or without atypia diagnosed by CNB were found in 9 and 332 lesions, respectively. Papillomas without atypia on CNB were treated by open excision (n = 265) or vacuum-assisted biopsy (VAB) (n = 67), which yielded similar event-free rate (p = 0.19). The upgrade rate of this group to higher-risk lesions was 9.9%. Peripheral (p = 0.011) lesions in postmenopausal (p = 0.001) or older (p = 0.001) patients with papillomas without atypia based on CNB showed significantly higher upgrade rates. Papillomas with atypia on CNB were all managed by open excision, and concurrent malignancy was found in two lesions.
CONCLUSION: In conclusion, our results support benign papillary lesions based on CNB require further treatment. Peripheral lesions occurring in older or postmenopausal women are at higher risk for upgrade.

Entities:  

Mesh:

Year:  2019        PMID: 31209512     DOI: 10.1007/s00268-019-05047-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  Are we overtreating papillomas diagnosed on core needle biopsy?

Authors:  Amy E Cyr; Deborah Novack; Kathryn Trinkaus; Julie A Margenthaler; William E Gillanders; Timothy J Eberlein; Jon Ritter; Rebecca L Aft
Journal:  Ann Surg Oncol       Date:  2010-11-03       Impact factor: 5.344

2.  Large volume "mammotome" biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast.

Authors:  P J Carder; T Khan; P Burrows; N Sharma
Journal:  J Clin Pathol       Date:  2008-05-21       Impact factor: 3.411

3.  Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium.

Authors:  Tehillah S Menes; Robert Rosenberg; Steven Balch; Shabnam Jaffer; Karla Kerlikowske; Diana L Miglioretti
Journal:  Am J Surg       Date:  2013-10-07       Impact factor: 2.565

4.  Papillary lesions of the breast: To excise or observe?

Authors:  Sidrah Khan; Adrian Diaz; Kellie J Archer; Rebecca R Lehman; Tiffany Mullins; Gilda Cardenosa; Harry D Bear
Journal:  Breast J       Date:  2017-08-27       Impact factor: 2.431

5.  Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up.

Authors:  Monica Rizzo; Jared Linebarger; Michael C Lowe; Lin Pan; Sheryl G A Gabram; Leonel Vasquez; Michael A Cohen; Marina Mosunjac
Journal:  J Am Coll Surg       Date:  2012-01-11       Impact factor: 6.113

6.  Management of ultrasonographically detected benign papillomas of the breast at core needle biopsy.

Authors:  Jung Min Chang; Woo Kyung Moon; Nariya Cho; Wonshik Han; Dong-Young Noh; In-Ae Park; Eun-Jung Jung
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

7.  Papillary lesions of the breast: outcomes of 156 patients managed without excisional biopsy.

Authors:  Paloma Wyss; Zsuzsanna Varga; Matthias Rössle; Christoph J Rageth
Journal:  Breast J       Date:  2014-05-26       Impact factor: 2.431

8.  Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge.

Authors:  Neslihan Cabioglu; Kelly K Hunt; S Eva Singletary; Tanya W Stephens; Sylvie Marcy; Funda Meric; Merrick I Ross; Gildy V Babiera; Frederick C Ames; Henry M Kuerer
Journal:  J Am Coll Surg       Date:  2003-03       Impact factor: 6.113

9.  [Management of non malignant papillary lesions diagnosed on percutaneous biopsy].

Authors:  R Plantade; F Gerard; J C Hammou
Journal:  J Radiol       Date:  2006-03

10.  Is surgical excision necessary in benign papillary lesions initially diagnosed at core biopsy?

Authors:  Won-Ho Kil; Eun Yoon Cho; Jung Han Kim; Seok-Jin Nam; Jung-Hyun Yang
Journal:  Breast       Date:  2007-11-28       Impact factor: 4.380

View more
  5 in total

1.  Intraductal Papilloma of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance.

Authors:  Jessica Limberg; Whitney Kucher; Genevieve Fasano; Syed Hoda; Aya Michaels; Jennifer L Marti
Journal:  Ann Surg Oncol       Date:  2021-04-19       Impact factor: 5.344

2.  Benign Breast Intraductal Papillomas Without Atypia at Core Needle Biopsies: Is Surgical Excision Necessary?

Authors:  Tanya Moseley; Bella Desai; Gary J Whitman; Emily K Robinson; Tamara Saunders; Anneliese Gonzalez; Hongying He
Journal:  Ann Surg Oncol       Date:  2020-08-28       Impact factor: 5.344

3.  Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.

Authors:  Xiaoli Zhang; Wenqing Liu; Tao Hai; Fei Li
Journal:  Ann Surg Oncol       Date:  2021-07-30       Impact factor: 5.344

Review 4.  Papillary neoplasms of the breast including upgrade rates and management of intraductal papilloma without atypia diagnosed at core needle biopsy.

Authors:  Edi Brogi; Melissa Krystel-Whittemore
Journal:  Mod Pathol       Date:  2020-10-26       Impact factor: 7.842

5.  Reconsidering the therapeutic use for vacuum-assisted breast biopsy in breast cancer patients: a retrospective single-center study.

Authors:  Jialin Zhao; Xuejing Wang; Ying Xu; Li Peng; Qiang Sun
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.